FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297539416> ?p ?o ?g. }

• W4297539416 endingPage "1379" @default.
• W4297539416 startingPage "1379" @default.
• W4297539416 abstract "The aim of the present study was to determine which individual or combined CpG sites among O6-methylguanine DNA methyltransferase CpG 74–89 in glioblastoma mainly affects the response to temozolomide resulting from CpG methylation using statistical analyses focused on the tumor volume ratio (TVR). We retrospectively examined 44 patients who had postoperative volumetrically measurable residual tumor tissue and received adjuvant temozolomide therapy for at least 6 months after initial chemoradiotherapy. TVR was defined as the tumor volume 6 months after the initial chemoradiotherapy divided by that before the start of chemoradiotherapy. Predictive values for TVR as a response to adjuvant therapy were compared among the averaged methylation percentages of individual or combined CpGs using the receiver operating characteristic curve. Our data revealed that combined CpG 78 and 79 showed a high area under the curve (AUC) and a positive likelihood ratio and that combined CpG 76–79 showed the highest AUC among all combinations. AUCs of consecutive CpG combinations tended to be higher for CpG 74–82 in exon 1 than for CpG 83–89 in intron 1. In conclusion, the methylation status at CpG sites in exon 1 was strongly associated with TVR reduction in glioblastoma." @default.
• W4297539416 created "2022-09-29" @default.
• W4297539416 creator A5006840327 @default.
• W4297539416 creator A5012395133 @default.
• W4297539416 creator A5015067006 @default.
• W4297539416 creator A5022912020 @default.
• W4297539416 creator A5032854314 @default.
• W4297539416 creator A5042627836 @default.
• W4297539416 creator A5047358040 @default.
• W4297539416 creator A5048930188 @default.
• W4297539416 creator A5049156104 @default.
• W4297539416 creator A5055935818 @default.
• W4297539416 creator A5058151515 @default.
• W4297539416 creator A5063532985 @default.
• W4297539416 creator A5069303697 @default.
• W4297539416 creator A5076017727 @default.
• W4297539416 creator A5081031377 @default.
• W4297539416 creator A5082324887 @default.
• W4297539416 creator A5083342160 @default.
• W4297539416 creator A5086562781 @default.
• W4297539416 date "2022-09-26" @default.
• W4297539416 modified "2023-09-26" @default.
• W4297539416 title "Volumetric Analysis of Glioblastoma for Determining Which CpG Sites Should Be Tested by Pyrosequencing to Predict Temozolomide Efficacy" @default.
• W4297539416 cites W1965705450 @default.
• W4297539416 cites W1995010744 @default.
• W4297539416 cites W2060133260 @default.
• W4297539416 cites W2068422827 @default.
• W4297539416 cites W2079232919 @default.
• W4297539416 cites W2096287682 @default.
• W4297539416 cites W2103645386 @default.
• W4297539416 cites W2105100844 @default.
• W4297539416 cites W2112739446 @default.
• W4297539416 cites W2146803439 @default.
• W4297539416 cites W2158681922 @default.
• W4297539416 cites W2162643152 @default.
• W4297539416 cites W2165871546 @default.
• W4297539416 cites W2614332772 @default.
• W4297539416 cites W2620622663 @default.
• W4297539416 cites W2885854788 @default.
• W4297539416 cites W2895493353 @default.
• W4297539416 cites W3158989562 @default.
• W4297539416 cites W4205360681 @default.
• W4297539416 cites W4223565124 @default.
• W4297539416 doi "https://doi.org/10.3390/biom12101379" @default.
• W4297539416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36291588" @default.
• W4297539416 hasPublicationYear "2022" @default.
• W4297539416 type Work @default.
• W4297539416 citedByCount "0" @default.
• W4297539416 crossrefType "journal-article" @default.
• W4297539416 hasAuthorship W4297539416A5006840327 @default.
• W4297539416 hasAuthorship W4297539416A5012395133 @default.
• W4297539416 hasAuthorship W4297539416A5015067006 @default.
• W4297539416 hasAuthorship W4297539416A5022912020 @default.
• W4297539416 hasAuthorship W4297539416A5032854314 @default.
• W4297539416 hasAuthorship W4297539416A5042627836 @default.
• W4297539416 hasAuthorship W4297539416A5047358040 @default.
• W4297539416 hasAuthorship W4297539416A5048930188 @default.
• W4297539416 hasAuthorship W4297539416A5049156104 @default.
• W4297539416 hasAuthorship W4297539416A5055935818 @default.
• W4297539416 hasAuthorship W4297539416A5058151515 @default.
• W4297539416 hasAuthorship W4297539416A5063532985 @default.
• W4297539416 hasAuthorship W4297539416A5069303697 @default.
• W4297539416 hasAuthorship W4297539416A5076017727 @default.
• W4297539416 hasAuthorship W4297539416A5081031377 @default.
• W4297539416 hasAuthorship W4297539416A5082324887 @default.
• W4297539416 hasAuthorship W4297539416A5083342160 @default.
• W4297539416 hasAuthorship W4297539416A5086562781 @default.
• W4297539416 hasBestOaLocation W42975394161 @default.
• W4297539416 hasConcept C104317684 @default.
• W4297539416 hasConcept C121608353 @default.
• W4297539416 hasConcept C125009961 @default.
• W4297539416 hasConcept C126322002 @default.
• W4297539416 hasConcept C140173407 @default.
• W4297539416 hasConcept C143998085 @default.
• W4297539416 hasConcept C150194340 @default.
• W4297539416 hasConcept C189235521 @default.
• W4297539416 hasConcept C190727270 @default.
• W4297539416 hasConcept C2776194525 @default.
• W4297539416 hasConcept C2777389519 @default.
• W4297539416 hasConcept C2777863537 @default.
• W4297539416 hasConcept C2778424827 @default.
• W4297539416 hasConcept C2779527866 @default.
• W4297539416 hasConcept C33288867 @default.
• W4297539416 hasConcept C502942594 @default.
• W4297539416 hasConcept C54355233 @default.
• W4297539416 hasConcept C71924100 @default.
• W4297539416 hasConcept C76318530 @default.
• W4297539416 hasConcept C86803240 @default.
• W4297539416 hasConcept C91965660 @default.
• W4297539416 hasConceptScore W4297539416C104317684 @default.
• W4297539416 hasConceptScore W4297539416C121608353 @default.
• W4297539416 hasConceptScore W4297539416C125009961 @default.
• W4297539416 hasConceptScore W4297539416C126322002 @default.
• W4297539416 hasConceptScore W4297539416C140173407 @default.
• W4297539416 hasConceptScore W4297539416C143998085 @default.
• W4297539416 hasConceptScore W4297539416C150194340 @default.
• W4297539416 hasConceptScore W4297539416C189235521 @default.
• W4297539416 hasConceptScore W4297539416C190727270 @default.

• next